ErkrankungEhlers-Danlos-Syndrom; Differentialdiagnose
Zusammenfassung
Umfassendes differentialdiagnostisches panel für Ehlers-Danlos Syndrom mit 5 Leitlinien-kuratierten core-Genen, 14 weiteren Leitlinien-kuratierten Genen sowie insgesamt 47 kuratierten Genen gemäß klinischer Verdachtsdiagnose
153,9 kb (Erweitertes Panel)
- EDTA-Blut (3-5 ml)
NGS +
[Sanger]
Genpanel
Ausgewählte Gene
Name | Exon-Länge (bp) | OMIM-G | Erbgang |
---|---|---|---|
COL1A1 | 4395 | AD | |
COL1A2 | 4101 | AD und/oder AR | |
COL3A1 | 4401 | AD und/oder AR und/oder Mult | |
COL5A1 | 5517 | AD | |
COL5A2 | 4500 | AD | |
TNXB | 12729 | AD und/oder AR | |
ADAMTS2 | 3636 | AR | |
AEBP1 | 3477 | AR | |
ALDH18A1 | 2388 | AD und/oder AR | |
ATP6V0A2 | 2571 | AR | |
ATP7A | 4503 | XLR | |
B3GALT6 | 990 | AR | |
B4GALT7 | 984 | AR | |
BGN | 1107 | XL | |
C1R | 1884 | AD | |
C1S | 2067 | AD | |
CBS | 1656 | AR | |
CHST14 | 1131 | AR | |
COL12A1 | 9192 | AD | |
COL6A1 | 3087 | AD und/oder AR | |
COL6A2 | 3060 | AD und/oder AR | |
COL6A3 | 9534 | AD und/oder AR | |
DSE | 2877 | AR | |
EFEMP2 | 1332 | AR | |
ELN | 2175 | AD | |
FBLN5 | 1347 | AD und/oder AR | |
FBN1 | 8616 | AD und/oder Mult | |
FBN2 | 8739 | AD | |
FKBP14 | 636 | AR | |
GORAB | 1185 | AR | |
LOX | 1254 | AD | |
LTBP4 | 4763 | AR | |
PLOD1 | 2184 | AR | |
PRDM5 | 1893 | AR | |
PYCR1 | 960 | AR | |
RIN2 | 2688 | AR | |
ROBO3 | 4161 | AR | |
SKI | 2187 | AD | |
SLC39A13 | 1095 | AR | |
SMAD3 | 1278 | AD | |
TGFB2 | 1245 | AD | |
TGFB3 | 1239 | AD | |
TGFBR1 | 1512 | AD | |
TGFBR2 | 1704 | AD | |
ZNF469 | 11862 | AR |
Infos zur Erkrankung
Die verschiedenen Typen des Ehlers-Danlos-Syndroms bilden eine heterogene Gruppe von Krankheiten, die durch Zerbrechlichkeit des weichen Bindegewebes gekennzeichnet sind und sich in der Haut, Bändern, Gelenken, Blutgefäßen und / oder inneren Organen manifestiert. Das klinische Spektrum ist sehr unterschiedlich und reicht von milder Haut- und Gelenküberbeweglichkeit bis hin zu schwerer körperlicher Behinderung und lebensbedrohlichen Gefäßkomplikationen. Eine Überlappung mit Osteogenesis imperfecta wird beobachtet. Zu den Krankheiten in dieser Gruppe gehören das klassische Ehlers-Danlos-Syndrom (EDS), das muskulokontrakturale EDS, das hypermobile EDS, das vaskuläre EDS, das Arthrochalasie-EDS, das Dermatosparaxis-EDS, das parodontale EDS, das X-chromosomale EDS, das spröde Hornhaut-Syndrom, das klassische EDS Typ 1 und Typ 2, Herz-Klappen-EDS, spondylodysplastisches EDS, myopathisches EDS und kyphoskoliotisches EDS.
Referenzen: https://www.ncbi.nlm.nih.gov/books/NBK1244/
https://www.ncbi.nlm.nih.gov/books/NBK541503/
https://www.ncbi.nlm.nih.gov/books/NBK1462/
https://www.ncbi.nlm.nih.gov/books/NBK1494/
https://www.ncbi.nlm.nih.gov/books/NBK1279/
- Allelic: Aortic valve disease 1 (NOTCH1)
- Allelic: Developmental + epileptic encephalopathy 93 (ATP6V1A)
- Allelic: Leukemia, Philadelphia chromosome-positive, resistant to imatinib (ABL1)
- Allelic: Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 (MYLK)
- Allelic: Mirror movements 1 and/or agenesis of the corpus callosum (DCC)
- Achondrogenesis, type II or hypochondrogenesis (COL2A1)
- Acromicric dysplasia (FBN1)
- Adams-Oliver syndrome 5 (NOTCH1)
- Al-Gazali syndrome (B3GALT6)
- Aortic aneurysm, familial thoracic 10 (LOX)
- Aortic aneurysm, familial thoracic 6 (ACTA2)
- Aortic aneurysm, familial thoracic 7 (MYLK)
- Arthrogryposis, distal, type 3 (PIEZO2)
- Arthrogryposis, distal, type 5 (PIEZO2)
- Arthrogryposis, distal, with impaired proprioception + touch (PIEZO2)
- Avascular necrosis of the femoral head (COL2A1)
- Bethlem myopathy 1 (COL6A1-3)
- Bethlem myopathy 2 (COL12A1)
- Bone mineral density variation QTL, osteoporosis (COL1A1)
- Brittle cornea syndrome 1 (ZNF469)
- Brittle cornea syndrome 2 (PTDM5)
- C1s deficiency (C1S)
- Caffey disease (COL1A1)
- Congenital heart defects + skeletal malformations syndrome (ABL1)
- Contractural arachnodactyly, congenital (FBN2)
- Cutis laxa, AD (ELN)
- Cutis laxa, AD 2 (FBLN5)
- Cutis laxa, AR, type IA (FBLN5)
- Cutis laxa, AR, type IB (EFEMP2)
- Cutis laxa, AR, type IIA (ATP6V0A2)
- Cutis laxa, AR, type IID (ATP6V1A)
- Cutis laxa, AR, type IIE (LTBP1)
- Cutis laxa, AR, type IIIA (ALDH18A1)
- Cutis laxa, autosomal recessive, type IC (LTBP4)
- Cutis laxa, autosomal recessive, type IIB-IIIB (PYCR1)
- Czech dysplasia (COL2A1)
- Ectopia lentis, familial (FBN1)
- Ehlers Danlos syndrome, musculocontractural type 1 (CHST14)
- Ehlers Danlos syndrome, type VI (PLOD1)
- Ehlers-Danlos syndrome due to tenascin X deficiency (TNXB)
- Ehlers-Danlos syndrome, arthrochalasia type, 1 (COL1A1)
- Ehlers-Danlos syndrome, arthrochalasia type, 2 (COL1A2)
- Ehlers-Danlos syndrome, cardiac valvular type (COL1A2)
- Ehlers-Danlos syndrome, classic type, 1 (COL5A1)
- Ehlers-Danlos syndrome, classic type, 2 (COL5A2)
- Ehlers-Danlos syndrome, classic-like, 2 (AEBP1)
- Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (PLOD1)
- Ehlers-Danlos syndrome, kyphoscoliotic type, 2 (FKBP14)
- Ehlers-Danlos syndrome, musculocontractural type 2 (DSE))
- Ehlers-Danlos syndrome, periodontal type, 1 (C1R)
- Ehlers-Danlos syndrome, periodontal type, 2 (C1S)
- Ehlers-Danlos syndrome, spondylodysplastic type, 1 (B4GALT7)
- Ehlers-Danlos syndrome, spondylodysplastic type, 2 (B3GALT6)
- Ehlers-Danlos syndrome, vascular type (COL3A1)
- Epiphyseal dysplasia, multiple, with myopia + deafness (COL2A1)
- Gaze palsy, familial horizontal, with progressive scoliosis, 1 (ROBO3)
- Gaze palsy, familial horizontal, with progressive scoliosis, 2 (DCC)
- Geleophysic dysplasia 2 (FBN1)
- Geroderma osteodysplasticum (GORAB)
- Homocystinuria, B6-responsive and nonresponsive types (CBS)
- Hypermobile Ehlers-Danlos syndrome (includes EDS type III)
- Kniest dysplasia (COL2A1)
- Kyphoscoliotic EDS (includes FKBP14-kEDS, PLOD1-kEDS)
- Legg-Calve-Perthes disease (COL2A1)
- Loeys-Dietz syndrome 1 (TGFBR1)
- Loeys-Dietz syndrome 2 (TGFBR2)
- Loeys-Dietz syndrome 3 (SMAD3)
- Loeys-Dietz syndrome 4 (TGFB2)
- Loeys-Dietz syndrome 5 (TGFB3)
- MASS syndrome (FBN1)
- Macrocephaly, alopecia, cutis laxa, scoliosis (RIN2)
- Macular degeneration, age-related, 3 (FBLN5)
- Macular degeneration, early-onset (FBN2)
- Marden-Walker syndrome (PIEZO2)
- Marfan lipodystrophy syndrome (FBN1)
- Marfan syndrome (FBN1)
- Meester-Loeys syndrome (BGN)
- Menkes disease (ATP7A)
- Moyamoya disease 5 (ACTA2)
- Multisystemic smooth muscle dysfunction syndrome (ACTA2)
- Neuropathy, hereditary, with or without age-related macular degeneration (FBLN5)
- Occipital horn syndrome (ATP7A)
- Osteoarthritis with mild chondrodysplasia (COL2A1)
- Osteogenesis imperfecta, type I-IV (COL1A1)
- Osteogenesis imperfecta, type II-IV (COL1A2)
- Platyspondylic skeletal dysplasia, Torrance type (COL2A1)
- Polymicrogyria with or without vascular-type EDS (COL3A1)
- Shprintzen-Goldberg syndrome (SKI)
- Spastic paraplegia 9A, AD (ALDH18A1)
- Spastic paraplegia 9B, AR (ALDH18A1)
- Spinal muscular atrophy, distal, X-linked 3 (ATP7A)
- Spondylocheirodysplasia, Ehlers-Danlos syndrome-like (SLC39A13)
- Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with/-out fractures (B3GALT6)
- Spondyloepimetaphyseal dysplasia, Strudwick type (COL2A1)
- Spondyloepimetaphyseal dysplasia, X-linked (BGN)
- Spondyloepiphyseal dysplasia congenita (COL2A1)
- Spondyloepiphyseal dysplasia, Stanescu type (COL2A1)
- Spondyloperipheral dysplasia (COL2A1)
- Stickler sydrome, type I, nonsyndromic ocular (COL2A1)
- Stickler syndrome, type I (COL2A1)
- Stiff skin syndrome (FBN1)
- Supravalvar aortic stenosis (ELN)
- Thrombosis, hyperhomocysteinemic (CBS)
- Ullrich congenital muscular dystrophy 1 (COL6A1-3)
- Ullrich congenital muscular dystrophy 2 (COL12A1)
- VISS s.: Vascular aneurysm, immune dysregulation, skeletal anomalies, skin/joint laxity (IPO8)
- Vitreoretinopathy with phalangeal epiphyseal dysplasia (COL2A1)
- Weill-Marchesani syndrome 2, AD (FBN1)
- Wrinkly skin syndrome (ATP6V0A2)
- AD
- AD und/oder AR
- AD und/oder AR und/oder Mult
- AD und/oder Mult
- AR
- XL
- XLR
- Multiple OMIM-Ps
Bioinformatik und klinische Interpretation
Kein Text hinterlegt